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Monocytes are one of the predominant cell types in the peripheral blood that are infected by human
cytomegalovirus (HCMV). Although virus can be detected in these cells in vivo, HCMV replication in cultured
monocytes has been unsuccessful. In this study, we demonstrate efficient HCMV replication in cultured
monocytes. HCMV permissiveness in these cells was dependent on nonadherent cell-induced stimulation of the
monocyte, with subsequent morphological differentiation into macrophages. Approximately 40% of the cells
infected by virus were detected by immunofluorescent staining with both immediate-early and late antibodies.
In addition, viral plaque assays demonstrated signfficant productive infection of macrophages. These
observations are consistent with the suggestion that the monocyte/macrophage serves as a source of viral
amplification and dissemination.
Human cytomegalovirus (HCMV) infection of immuno-
compromised patients often results in acute disease (10). The
virus may also contribute to the immune dysfunction ob-
served in these individuals by directly infecting lymphoid
cells (3, 19). HCMV immunosuppression is exemplified by a
depressed lymphocyte response to T-cell mitogens (3, 13, 27,
32), decreased natural killer cells (11, 28), and cytotoxic
T-lymphocyte activities in in vitro studies (27). The T cell
may also be functionally impaired without being produc-
tively infected (2, 12, 28). This observation is attributed to
suppression of various monocyte accessory cell functions
including suppression of interleukin 1 production (12, 14, 23)
and depressed T-cell proliferative responses to mitogens,
such as concanavalin A (ConA) (3, 19, 21) or pokeweed (19,
21), because of HCMV infection. Therefore, cells of the
peripheral blood may serve as a target as well as a potential
source of viral persistence.
With the advances in immunocytochemical techniques
and in situ hybridization, cell types naturally infected by
HCMV have been identified in the peripheral blood (20) and
tissues (8, 15) of acutely infected individuals. Studies of
separated cell populations from the peripheral blood in
natural or in vitro HCMV infections have demonstrated
monocytes (5, 12, 19), T cells (1, 6), and neutrophils (27, 32)
as the predominant infected cell types. In HCMV asympto-
matic patients, viral infection of peripheral blood cells is
infrequent and expression appears to be restricted to early
events (1, 4, 5, 19). However, in patients with acute HCMV
infection, virus can be frequently isolated from these cells (3,
20, 24). Polymorphonuclear cells may harbor viral DNA;
however, expression has not been detected, suggesting that
these cells may phagocytize viral particles (32). Examination
of biopsies from transplanted organs of patients with HCMV
disease indicates that mononuclear inflammatory cells are
the predominant infected cell type (8, 36). Both the fre-
quency and the extent of viral expression in infected infil-
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trating cells are increased in these tissues relative to the
incidence of virus in cells of the peripheral blood. Since
infiltrating cells are in a state of activation, the increased
incidence of virus detected in these cells may be due to
cellular induction of viral replication.
Cellular differentiation has been observed to correlate
with productive HCMV infection in a few cell lines. For
example, the monocytic cell line THP-1 is permissive for
HCMV after 12-O-tetradecanoylphorbol-13-acetate-induced
differentiation of the monocyte into a macrophage (34).
Similar results were also observed with the teratocarcinoma
cell line (N-Tera-2) (9). In these systems, HCMV replicates
in differentiated but not undifferentiated cells. These obser-
vations might suggest that either differentiation events are
linked to HCMV activation or the virus productively infects
only terminally differentiated cells.
HCMV infection of peripheral blood mononuclear cells in
vitro has demonstrated viral expression in a few cells re-
stricted to early viral events. One of the major cell types
infected by HCMV in these cultures is monocytes (1, 4, 5,
19). A variety of different culture methods have been devel-
oped by several groups to study the growth of HCMV and
other viruses in primary monocyte/macrophage cultures (2,
3, 7, 11, 18, 19, 30). Most of these culture systems are
heavily reliant on continuous exposure of various cytokines
and mitogens in the growth medium, but to date none of
these primary culture systems have been successful in
replicating HCMV. Recently, a primary monocyte/macro-
phage culture system which relies on antigenically or mito-
genically activated T-cell contact with monocytes was de-
scribed (25). Stimulated monocytes differentiate into
multinucleated giant cells (MNGCs) and can be maintained
in culture for months without the addition of exogenous
cytokines. This differentiation pathway may mimic the acti-
vation of monocytes into macrophages observed in vivo by
antigen-specific reaction with activated T cells. We have
employed these monocyte/macrophage culture techniques
on cells derived from normal donors to examine HCMV
replication in the differentiating cells. We demonstrate that
HCMV can productively infect monocyte/macrophages, de-
pending on the stage of morphological differentiation.
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MATERIALS AND METHODS
Isolation and culture of macrophages. Peripheral blood
mononuclear cells were isolated from the blood of HCMV
seronegative donors screened by an enzyme-linked immuno-
sorbent assay. All blood donors were arranged through the
General Clinic Research Center at the Scripps Clinic and
Research Foundation. The cells were collected by underlay-
ing heparinized treated whole blood with Histopaque (Sigma
Chemical Co., St. Louis, Mo.) and centrifuged at 1,500 rpm
in a Beckman T6 centrifuge for 25 min at room temperature.
The peripheral blood mononuclear cell band was collected,
washed twice with sterile saline and once with serum-free
media, and resuspended to 4 million cells per ml in Iscove's
medium (GIBCO Laboratories, Grand Island, N.Y.) with
penicillin-streptomycin and 10% pooled human serum from
laboratory personnel seronegative for human immunodefi-
ciency virus (HIV) and HCMV. Approximately 5 million
nonadherent and adherent cells were plated onto Primaria
culture dishes (60 by 15 mm) (Becton Dickinson, Lincoln
Park, N.J.) and incubated at 37°C with 7.5% CO2. Unstim-
ulated adherent cells were allowed to adhere for 90 min, at
which time all nonadherent cells were removed with incom-
plete 60/30 medium (60% AIM V, 30% Iscove's medium
[both from GIBCO], penicillin-streptomycin) and replaced
with 3 ml of fresh complete 60/30 medium containing 10%
pooled human serum. Adherent cells stimulated for differ-
entiation were treated with the addition of ConA (10 jig/ml)
and incubated for 20 h. The following day, all nonadherent
cells were removed and 3 ml of fresh complete 60/30 medium
was added. Every 4 or 5 days, the adherent monocyte
cultures were fed complete 60/30 medium by replacing
one-half of the old medium with fresh medium. Day 1 of
differentiation is defined as the day after the initial peripheral
blood mononuclear cell isolation and stimulation with ConA.
Characterization of adherent monocyte cultures. The ad-
herent cells were greater than 98% esterase positive at 72 h.
The nonspecific esterase staining was performed by using a
kit from Sigma. Cells were also characterized as monocytic
by immunocytochemistry with the monoclonal antibodies
Leu Ml, M3, 3a, and 3b and found to be 98 to 100% positive
for these markers (Becton Dickinson and Co., Mountain
View, Calif.). In these studies, approximately 70% of the
monocyte cultures differentiated into MNGCs. The remain-
ing monocyte cultures either did not differentiate or self
differentiated without ConA stimulation. This observation
was associated with either the batch of human serum used or
specific cell donor variation. For the purposes of this study,
only cultures that were 98% esterase positive and exhibited
appropriate differentiation with ConA and lymphocyte stim-
ulation were used.
In vitro infection of monocyte/macrophages. The recent
isolate of HCMV, I-G, (19) was used to infect primary
cultures of monocyte/macrophages. The frozen stock of I-G,
originally isolated from an adult patient with mononucleosis,
had been passaged through human fibroblasts (HFF) and
frozen at passage 12 in liquid nitrogen. Consequently, frozen
samples from this stock were thawed and passaged for one to
five additional rounds through HFF cells prior to monocyte/
macrophage infections. Sonicated HCMV-infected HFF cell
lysates were used as the source of virus, which was diluted
1:1 with monocyte/macrophage-conditioned medium. Mono-
cyte/macrophage cultures containing 5 x 105 cells per dish
(60 by 15 mm) were infected at various days during differ-
entiation with infected lysates containing approximately 108
PFU per dish. The virus was allowed to adhere for 12 h,
washed, and then replaced with conditioned medium.
Immunofluorescence of CMV immediate early and late
antigen. In vitro HCMV-infected monocyte/macrophages
were fixed in methanol and reacted at a dilution of 1:100 with
immediate-early (IE) (L-14) (19) and late (L) (J-24) monoclo-
nal antibodies for 2 h at 370C. The J-24 monoclonal antibody
was characterized by its ability to detect antigen late in the
HCMV life cycle. The kinetic appearance of the antigen
occurred after viral DNA synthesis (unpublished results).
The secondary antibody (Becton Dickinson)-goat anti-
mouse fluorescein conjugate (1:100) was reacted with the
HCMV monoclonal antibodies for 1 h at 370C. The infected
monocyte/macrophages used for immunofluorescence were
cultured in four chamber plastic slides (Nunc Inc., Naper-
ville, Ill.).
Viral absorption and penetration assays. Five millicuries of
[methyl-1,2-3H]thymidine (100 to 130 Ci/mmol; Amersham
Corp., Arlington Heights, Ill.) was used to metabolically
label virions in six 162-cm2 flasks of HFF cells after an initial
36 h of infection. The cells were incubated with [3H]thymi-
dine for 48 h with fresh medium containing 2% dialyzed fetal
calf serum. The infected cells were then sonicated, and the
cellular debris was pelleted. Labeled virus in the supernatant
was pelleted through a 20% cushion of sorbitol Tris-buffered
saline (pH 8.0) for 90 min in a Sorvall SA 600 rotor at 16,000
rpm and then further purified through a six-step sorbitol
gradient ranging from 20 to 70%. Gradients were spun in a
Beckman SW41 rotor for 2 h at 18,000 rpm. The white
opulent viral band was collected between the 50 and 60%
interface and diluted 10-fold with 60/30 macrophage medium.
Approximately equal numbers of macrophage cells (2.2 x
104) and HFF cells (5.6 x 104) were infected with 100,000
cpm of 3H-labeled HCMV. An initial 4-h incubation period in
minimal volume was performed to allow for adherence; then
the infected cells were harvested, and additional medium
was collected 12 h after the initial infection. The infected
cultures were then fractionated into four fractions, and the
levels of radioactivity were assessed in a Beckman LS
5000TD scintillation counter. The first fraction (free virus)
consisted of medium pooled with one saline wash of the
cells. The second fraction (attached virus) consisted of virus
released from the surface by incubation with trypsin for 5
min. The cells were again washed thoroughly, and the
trypsin-released virus and wash were combined. The third
fraction (intercellular virus) consisted of supernatant from
the Dounce-homogenized cells pelleted through a sucrose
gradient. The fourth fraction (nuclear viral DNA) consisted
of the nuclei pellet resuspended in saline. The radioactivity
was counted with a hemacytometer. The number of nuclei
isolated was used to normalize the radioactive counts in each
of the fractions tested. HFF cells were infected with labeled
virus to assess virulence. Labeled virus was found to be
infectious by the development of a cellular cytopathic effect.
Viral titer assay. HFF and unstimulated and stimulated
macrophage cultures were infected as previously described.
After 20 h, infected cells were washed and fresh 60/30
medium was added. On various days postinfection, medium
and cells were then collected in aliquots and frozen at
-70°C. At the end of a collection period, the cells and
medium were then thawed, sonicated, and plated at various
dilutions between 101 and 10-7 onto six-well plates con-
taining HFF cells at approximately 80% confluency. After an
initial 1 h of adherence, ME-medium 199 (GIBCO) solution
containing 0.5% SeaKem agarose, 4% glutamine, 10% fetal
calf serum, and penicillin-streptomycin was overlaid, and
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FIG. 1. Morphological differentiation of monocytes into MNGCs. Peripheral blood monocytes were isolated from an HCMV-seronegative
donor and stimulated by contact with activated nonadherent cells, as described in Materials and Methods. Cells were cultured for 1 (A), 4
(B), 9 (C), and 14 (D) days poststimulation with the nonadherent fraction. MNGCs are seen in the 9- and 14-day cultures. The formation of
MNGCs may occur between 6 and 15 days poststimulation depending on the donor. Magnification, x 100.
the cultures were allowed to incubate for 10 to 12 days, with
occasional feeding. Cells were fixed with a 25% formalin-
phosphate-buffered saline solution for 10 to 15 min and
stained with a 0.05% solution of methylene blue (Ricca
Chemicals) (35).
RESULTS
Macrophage culture characteristics. The morphological
differentiation of the monocyte cultures was based on a 20-h
stimulation of the monocyte-derived adherent cells and the
lymphocyte-derived nonadherent cell fractions in the pres-
ence of 10 ,ug/ml of ConA. A fivefold increase or decrease in
the concentration of ConA resulted in detachment of adher-
ent cells within several days of initial stimulation. After the
initial stimulation and washing of adherent cells, a 30 to 40%
fraction of adherent cells, referred to as short-term adher-
ents (29, 37), detached from the surface of the plate and were
removed by further washes (Fig. 1A). This process occurred
over a period of 3 to 4 days poststimulation (Fig. 1B). The
remaining attached cells slowly increased in size (Fig. 1C),
and some fused and formed MNGCs (Fig. 1D). Cells at the
two later stages were greater than 98% esterase positive
(Fig. 2) and could be maintained in culture for several
months. MNGCs were observed as early as 6 or as late as 25
days poststimulation. Individual donors demonstrated dif-
ferent rates and frequencies of MNGC formation. The cel-
lular morphology associated with activated nonadherent
cell-induced differentiation of monocytes was similar to that
of long-term primary macrophage cultures previously re-
ported (29, 37).
Expression of HCMV in human primary macrophage cul-
tures infected in vitro. The ability ofHCMV to infect primary
macrophage cultures stimulated by contact with activated
nonadherent cells was examined at various times poststim-
ulation. For these studies, the low-passage, recent isolate of
HCMV, I-G, was used to infect monocyte/macrophage cul-
tures at days 1, 4, and 16 poststimulation. Cells were fixed at
various days postinfection and tested for the presence of the
HCMV IE and L antigens by immunofluorescence. The
results presented are derived from four experiments with
monocyte cultures from four individual donors exhibiting
various rates of differentiation of the monocyte cultures. The
precise kinetics for the appearance of viral antigens varied
from donor to donor, but a correlation was observed be-
tween increased frequencies of cells expressing viral anti-
gens and the overall degree of morphological differentiation
VOL. 65, 1991
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FIG. 2. The presence of esterase in macrophage cultures. Peripheral blood monocytes stimulated by contact with activated nonadherent
cells were stained after 6 days for the presence of nonspecific esterase activity. The charcoal granules characteristic of esterase activity was
observed in 98% of the cells. Cells were counterstained with hematoxylin. Magnifications, x 100 (A) and x200 (B).
of the monocyte/macrophage culture. Day-i-infected cul-
tures tested for the presence of IE antigen demonstrated
little or undetectable levels of the protein at 1, 6, and 13 days
postinfection (data not shown). We observed that infection
of early differentiating cells (1 to 3 days poststimulation),
prior to the formation of MNGCs, often impaired or inhib-
ited further morphologic differentiation. When monocytes
were infected at day 4 poststimulation, approximately 1% of
the cells at 24 h postinfection demonstrated the presence of
IE antigen by immunofluorescence. The percentage of cells
with IE antigen increased to 20% as morphologic differenti-
ation occurred at 6 to 13 days postinfection (Fig. 3B, C, and
E). L antigen was detected in day-4-infected cultures and
paralleled the increase in the percentage of IE-positive cells
(Fig. 3D). The 16-day-old macrophages in which MNGCs
composed 2 to 4% of the cultures also demonstrated higher
frequencies of infectivity without any noticeable cytopathic
effect. These cultures demonstrated the greatest degree of
morphological differentiation and exhibited infectivity rates
of up to 40% of the cells at 6 to 13 days postinfection by
immunofluorescence for the presence of IE and L antigens.
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FIG. 3. The presence ofHCMV proteins in macrophage cultures. HCMV-infected macrophages were stained by immunofluorescence for
the presence of IE (B, C, and E) and L (D) viral antigens by using mouse monoclonal antibodies and techniques as described in Materials and
Methods. The characteristic IE staining was observed in the nucleus of macrophages (B and C) and MNGCs (E). L viral antigen was also
observed with these cells (D). Mock-infected cultures did not stain for IE (A) or L (data not shown) antigens. Magnification, x200.
Table 1, which demonstrates the frequency of HCMV infec-
tion of macrophage cultures infected and harvested at vari-
ous days postinfection for one individual donor.
Virus penetration in 1-day cultures. To determine whether
the lack of HCMV antigen expression in day-i-infected
monocyte cultures was due to the inability of the virus to
attach to and penetrate the cells, monocytes were infected
with HCMV containing 3H-labeled genomic DNA. Day 1
monocytes and permissive HFF cells of equivalent cell
numbers were infected with equal counts of labeled virus (1
x 105 cpm). At 12 h postinfection, cells were washed,
TABLE 1. Frequency of HCMV infection in
macrophage cultures
% of cells positive for viral antigen at
Day of postinfection day
differentiationa
1 6 13
1 0 0 0
4 <1 =20 NTb
16 <1 <1 =40
a Macrophage cultures were infected at either day 1, 4, or 16 poststimula-
tion with activated nonadherent cells.
b NT, not tested.
fractionated, and assayed for the presence of 3H-labeled
viral DNA in the nucleus and cytoplasm and on the cell
surface. Upon harvest and quantitation, 75 to 80% of the
label was recovered from both cultures. Approximately 3%
of the label was found in the cytoplasmic fraction or attached
to the surface of the monocytes, while 6% of the labeled
virus was recovered from these fractions ofHFF cells. After
the counts found in each fraction were normalized to the
number of nuclei isolated, similar amounts of 3H-labeled
viral DNA were recovered from the nuclei of both the
permissive HFF cells and the nonpermissive day 1 mono-
cyte/macrophages (Table 2). Therefore, the results suggest
that viral absorption and penetration are not involved in the
lack of HCMV expression observed in day 1 monocyte/
macrophage cultures.
HCMV productively infects differentiated macrophages.
The presence of late HCMV gene products in the infected
morphologically differentiated macrophage cultures sug-
gested that the virus productively infected these cells. To
test this hypothesis, a series of one-step viral growth analy-
sis was performed with infected cell lysates and supematants
from unstimulated monocytes as well as day 1 and day 10
nonadherent-cell-activated monocyte/macrophages. Cells
infected with HCMV demonstrated little cytopathic effect.
Viral plaque assays of HFF with day-10-infected monocyte/
VOL. 65, 1991
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HFF 1,100 490 80
Monocyte/macrophage 1,400 800 77
a Monocyte cultures were infected 1 day poststimulation with activated
nonadherent cells with 3H-labeled HCMV. At 12 h postinfection, cells were
washed, fractionated, and assayed for the presence of 3H-labeled viral DNA
in the nucleus and cytoplasm and on the cell surface with a scintillation
counter.
macrophage cell lysates demonstrated the highest levels of
viral replication titers so far reported, with titers ranging
from 105 to 107 PFU/ml (Fig. 4). Each time point on the
graph represents approximately 4 x 105 cells per infected
dish and at the peak of infection averages a titer of 25 PFU
per cell. The highest titers of virus in the macrophage
cultures again correlated with the maturity of the stimulated
monocyte/macrophage cultures, as evidenced by the forma-
tion of MNGCs. In contrast, HCMV infection of day-l-
stimulated cultures resulted in a 4-to-5-log decrease in viral
titers. The infection of unstimulated cultures produced min-
imal amounts of virus (Fig. 4). To determine whether virus
was released from infected cells, supernatants were assayed
for the presence of HCMV. Virus was not detected in any of
the above-described supernatants, suggesting that HCMV
may be predominantly cell associated in the monocyte/
macrophages (data not shown).
DISCUSSION
Replication of HCMV in monocyte/macrophages. This
study demonstrates that HCMV can productively infect
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FIG. 4. An HCMV one-step growth curve for infected macro-
phages. Macrophage cultures were infected at a multiplicity of
infection of 100 at days 0 (0), 1 (-), and 10 (A) poststimulation with
activated nonadherent cells, as described in Materials and Methods.
Cells were harvested at the indicated times, and viral titers were
determined by plaque assay of HFF.
productive replication of HCMV in primary cells from the
hematopoietic system. This report supplies direct evidence
that the monocyte/macrophage may play an important role in
the biology of HCMV and addresses the requirement of
cellular activation and differentiation as a prerequisite for
HCMV expression and permissiveness in this cell type.
Mature differentiated cultures of monocyte/macrophages
exhibiting the presence of MNGCs generated the highest
titers (107 PFU/ml) of HCMV without the development of
any discernible cytopathic effect. However, monocyte/mac-
rophage cultures infected at either day 0 or day 1 produced
an amount of HCMV that was 4 to 5 logs lower than that of
day-10-infected cultures. In agreement with these observa-
tions, the immunofluorescence data demonstrated a high
percentage of cells expressing viral antigens at the later
stages of differentiation. Although minimal viral replication
was detected in the viral titer assays, the immunofluores-
cence experiments showed no detectable viral expression in
day-l- and day-0-infected cultures. A possible explanation
for the apparently conflicting observations may be related to
the levels of sensitivity inherent in the different assays.
Alternatively, the low levels of viral replication in the early
monocyte/macrophages may indicate subpopulations of
monocytes that have spontaneously differentiated. Sponta-
neously differentiating monocytes may have arisen by prior
stimulation in vivo or at some point during the culturing
procedure. In our experience, this differentiated subpopula-
tion makes up approximately 0.01% of the total culture.
Supernatants from HCMV productively infected macro-
phages did not contain virus, suggesting that HCMV may be
tightly cell associated in these cultures. Similar results with
HIV in which the virus is restricted to monocyte vesicles
that fail to egress from the cell have been reported (18). This
phenomenon may be related to either HIV strain differences
or a unique property of the macrophage. Future studies with
other HCMV strains will determine whether strict cell asso-
ciation is a common feature of virus infection of macro-
phages.
Previous studies ofHCMV infection of primary monocyte/
macrophage cultures have reported low frequencies of infec-
tion, with expression restricted to early viral events (1, 4, 5,
19). The inability to replicate HCMV in these primary human
mononuclear cell cultures has been hypothesized to be due
to the limited survival time of these cells in vitro (22). Most
macrophage culture systems rely on the addition of various
cytokines (granulocyte-macrophage or macrophage colony-
stimulating factor or tumor necrosis factor), which may
produce varying degrees of stimulation. In the system de-
scribed in this report, activated nonadherent cell stimulation
of the monocyte for 20 h is sufficient to induce morphological
differentiation and produce cultures that survive up to sev-
eral months without further stimulation. Our ability to main-
tain these differentiated cells in culture for extended periods
of time may explain our success in infecting these cells.
Prior studies that used this culture system have suggested
that the T lymphocyte is, most likely, the cell in the
nonadherent cell population responsible for stimulation of
the monocyte. This conclusion is based on experiments in
which antibodies directed against the DR locus of class II
restriction blocks monocyte differentiation as well as HIV
reactivation (25). This T-cell-monocyte requirement is be-
lieved to mimic the T-cell-monocyte interactions that occur
in vivo and, therefore, provides an excellent model system
for studying viral monocyte/macrophage interactions.
Differentiation and HCMV replication. The importance of
differentiation as a prerequisite for HCMV replication has
J. VIROL.
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been demonstrated in other cell systems. For example, when
the monocyte cell line THP-1 is treated with 12-0-tetrade-
canoylphorbol-13-acetate, the cells exhibit a macrophage
phenotype (31). Undifferentiated THP-1 cells are resistant to
HCMV infection, whereas differentiated cells are permissive
for virus replication (34). The human teratocarcinoma cell
line N-Tera-2 is another example of how differentiation
dramatically affects the fate of HCMV replication. In this
cell line, HCMV replicates in differentiated but not undiffer-
entiated cells (9). Similar to that of primary macrophages,
the timing of HCMV infection of N-Tera-2 cells during the
differentiation process is crucial for production of virus.
When cells are infected early in the differentiation process, a
limited amount of virus is detectable. Maximal amounts of
HCMV are produced only in terminally differentiated cells.
This observation parallels the monocyte/macrophage system
in which optimal amounts of virus are recovered from older
macrophage cultures. The block in HCMV replication in the
N-Tera-2 cell line occurs at the transcriptional level of the
major IE promoter, which regulates the transcriptional acti-
vator genes of the virus (17). A similar mechanism may also
regulate HCMV expression in the monocyte/macrophages.
Studies with labeled virus show that the block in HCMV
expression in nonpermissive unstimulated monocytes is not
at the level of absorption and penetration into the cell. Other
posttranscriptional events, however, may regulate viral rep-
lication in these cells.
The role of the monocyte/macrophage in HCMV biology.
The observation that HCMV can productively infect mono-
cyte/macrophages suggests that the virus can directly per-
turb an important component of the immune system as well
as serve as a vector for viral dissemination into various
tissues. However, we have been unable to reactivate HCMV
from the monocyte/macrophage cultures of HCMV-seropos-
itive patients, suggesting that monocytes are not latent
sources of virus (unpublished observations). Our results
would indicate that permissiveness of macrophages to
HCMV infection is dependent on the extent of cellular
differentiation. Therefore, macrophages may serve as a
source of viral amplification. Thus, similar to those of HIV,
T cells and monocytes play a critical role in the biology of
HCMV. The viruses, however, may utilize the cells for
different purposes. Whereas the monocyte is a reservoir and
vector for HIV, it appears to serve as a vector and amplica-
tion unit for HCMV. Future studies will be required to
understand the mechanisms involved in T-cell-induced
expression of HCMV in the monocyte.
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